NAP1L1 and breast cancer: The levels of LANA and NAP1L1 were detected by anti-LANA and anti-NAP1L1 antibodies, which showed efficient reduction of target proteins in the indicated shRNAs transduced BCBL-1 and BC-3 cells (Fig. 5E,F).